Company Overview of Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. develops medicines for the treatment of inherited mitochondrial diseases. It offers EPI-743 and EPI-A0001 orally absorbed small molecules. Edison Pharmaceuticals, Inc. has a strategic alliance with Dainippon Sumitomo Pharma Co., Ltd. The company was founded in 2005 and is based in Mountain View, California with additional offices in the Netherlands. Edison Pharmaceuticals, Inc. operates as a subsidiary of Galileo Pharmaceuticals, Inc.
350 North Bernardo Avenue
Mountain View, CA 94043
Founded in 2005
Key Executives for Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Achelios Therapeutics LLC||United States|
|Helsinn Therapeutics (U.S.), Inc.||United States|
|Carlsbad Technology, Inc.||United States|
|Pharmasol Corporation||United States|
|Libertas Pharma Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Edison Pharmaceuticals, Inc., please visit www.edisonpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.